| ALL (81 patients) | ALS-nci (49 patients) | ALS-ci (32 patients) | P value |
---|---|---|---|---|
Male | 48 (59.3%) | 30 (61.2%) | 18 (56.3%) | 0.656 |
Education time (years) | 9 [9–12] | 12 [9–12] | 7.5 [6–9] | < 0.001 |
Age at onset (years) | 54.3 ± 11.1 | 51.0 ± 10.9 | 59.3 ± 9.6 | < 0.001 |
Age at testing (years) | 54.9 ± 11.2 | 51.6 ± 10.9 | 60.1 ± 9.6 | < 0.001 |
Disease duration (months) | 12 [7–18] | 11 [6–16] | 14 [9–21] | 0.025 |
BMI (kg/m2) | 22.10 ± 2.94 | 22.36 ± 3.22 | 21.70 ± 2.44 | 0.368 |
Site of onset | Â | Â | Â | 0.430 |
Bulbar | 15 | 7 | 8 | Â |
limb | 64 | 41 | 23 | Â |
mixed | 2 | 1 | 1 | Â |
ALSFRS-R score | 42 [36.5–45] | 42 [36–46] | 39 [37–43.5] | 0.309 |